SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Home on the range where the buffalo roam

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: horsegirl48 who wrote (734)5/18/2001 10:00:20 AM
From: Venkie  Read Replies (1) of 13815
 
Protein Design Labs Inc. (PDLI) - This biotech develops human and
humanized monoclonal antibodies to prevent and treat autoimmune
diseases, inflammatory conditions, viral infections, and cancer. On May
14th the company announced earnings of 0.14, beating the street by 0.06
and way up from the year-ago 0.02. Dain Rauscher Wessels followed the
news with a reiteration of its "strong buy speculative." Thursday the
stock surged 6.15 to close at 70, its high of the day and just under
200 DMA resistance. Plan to enter long over 71.29, if PDLI can clear
the 200 DMA. If the stock pulls back first, look for an opportunity to
go long on a bounce near the 58-60 level. Optionable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext